The North America percutaneous mechanical circulatory support devices market is witnessing significant expansion, driven by the increasing prevalence of cardiovascular diseases, technological advancements, and rising demand for minimally invasive procedures. These devices are widely used to provide temporary cardiac support in patients suffering from severe heart conditions such as cardiogenic shock and high-risk percutaneous coronary interventions. The region, led by the United States, holds a dominant share in the global market due to its advanced healthcare infrastructure, high healthcare spending, and strong presence of key market players.
In recent years, the Percutaneous Mechanical Circulatory Support Devices Market Growth Outlook has remained highly promising, supported by continuous innovation and favorable reimbursement policies. Increasing awareness among healthcare providers and patients regarding the benefits of early cardiac intervention is further accelerating adoption rates. Additionally, the growing geriatric population in North America, which is more susceptible to heart diseases, is contributing to sustained market demand. The integration of advanced technologies such as real-time monitoring and improved device efficiency is expected to create new growth avenues in the coming years.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003194
The percutaneous mechanical circulatory support devices market was valued at US$ 1,474.28 million in 2019 and is projected to reach US$ 3,964.75 million by 2027; it is expected to grow a ta CAGR of 13.5% during 2020–2027.
One of the primary factors driving the North American market is the rising incidence of lifestyle-related cardiovascular disorders, including hypertension, obesity, and diabetes. These conditions significantly increase the risk of heart failure, thereby boosting the demand for mechanical circulatory support systems. Furthermore, the growing preference for minimally invasive procedures over traditional surgical methods has fueled the adoption of percutaneous devices, which offer reduced recovery time and lower complication risks.
Technological advancements have played a crucial role in shaping the market landscape. Innovations such as improved catheter designs, enhanced hemodynamic support, and compact device structures have increased the efficiency and safety of these systems. Moreover, the introduction of portable and user-friendly devices has expanded their use in emergency settings and ambulatory care. Research and development activities, supported by both private and public funding, continue to drive product innovation and improve clinical outcomes.
The regulatory environment in North America also supports market growth. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) have streamlined approval processes for life-saving medical devices, enabling faster commercialization. Additionally, favorable reimbursement policies encourage healthcare providers to adopt advanced circulatory support technologies, thereby contributing to market expansion.
Hospitals and specialty cardiac centers represent the largest end-user segment in the region. These facilities are equipped with advanced infrastructure and skilled professionals required for complex cardiac procedures. The increasing number of cardiac catheterization laboratories and the growing availability of trained interventional cardiologists are further enhancing the adoption of percutaneous mechanical circulatory support devices.
Despite the positive outlook, the market faces certain challenges. High device costs and procedural expenses may limit accessibility, particularly in smaller healthcare facilities. Additionally, the risk of complications such as bleeding, infection, and vascular injury remains a concern. However, ongoing technological improvements and increasing clinical expertise are expected to mitigate these challenges over time.
The competitive landscape of the North America percutaneous mechanical circulatory support devices market is characterized by the presence of several established players focusing on innovation, strategic collaborations, and mergers and acquisitions. Companies are investing heavily in research and development to introduce next-generation devices with improved performance and safety features.
Top Players in the Market
- Abbott.
- Medtronic
- Getinge AB
- Teleflex Incorporated
- Livanova Plc (Cardiacassist, Inc.).
- Abiomed
- Eurosets
- Berlin Heart
- Jarvik Heart, Inc.
- CardioBridge GmbH
Future Outlook: -
The North America percutaneous mechanical circulatory support devices market is poised for robust growth, driven by increasing cardiovascular disease burden, technological advancements, and supportive regulatory frameworks. While challenges such as high costs and procedural risks persist, continuous innovation and expanding healthcare infrastructure are expected to overcome these barriers. As demand for minimally invasive cardiac interventions continues to rise, the market is likely to experience sustained growth, offering significant opportunities for both existing players and new entrants.
Related Report:
1) Vascular Screening Market Growth, Trends & Demand by 2034
2) Aortic Repair Devices Market Share, Size & Demand by 2034
3) Stromal Vascular Fraction Market Demand, Size & Forecast by 2034
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
